StockData
Danaher Corp logo

Danaher Corp

DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026Score 12/3027% above fair value
$227.97−4.26 (-1.83%)

Close on Nov 2, 2026Market cap $160.26BP/E 40.5Yield –

Danaher OpenFDA by Quarter

openFDA — MAUDE Adverse Event Reports for the Danaher Ecosystem

QuarterlyAnnualMonthly

Danaher OpenFDA: 935 in Q3 2026, up 229.2% from a year earlier.

Latest, Q3 2026
935
Period ended Sep 30, 2026
Change on a year earlier
+229.2%
284 in Q3 2025
History
47 quarters
Since Q1 2015
Sources
1
U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE)

Where the Q3 2026 figure comes from

Source: U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗

Reported in U.S. FDA openFDA MAUDE Adverse Event API.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedopenFDA — MAUDE Adverse Event Reports for the Danaher EcosystemYear on yearSource
Q3 2026Sep 30, 2026935+229.2%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q2 2026Jun 30, 2026467+48.7%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q1 2026Mar 31, 2026365+14.4%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q4 2025Dec 31, 2025326+21.6%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q3 2025Sep 30, 2025284-11.3%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q2 2025Jun 30, 2025314+27.6%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q1 2025Mar 31, 2025319+18.6%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q4 2024Dec 31, 2024268+8.5%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q3 2024Sep 30, 2024320+14.7%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q2 2024Jun 30, 2024246-6.1%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q1 2024Mar 31, 2024269-26.9%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q4 2023Dec 31, 2023247-5.4%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q3 2023Sep 30, 2023279+6.5%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q2 2023Jun 30, 2023262-34.3%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q1 2023Mar 31, 2023368-2.4%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q4 2022Dec 31, 2022261-41.3%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗

Breakdown

What makes up openFDA

Cite this data

StockData. (2026). Danaher OpenFDA, quarterly Q1 2015–Q3 2026 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/ext-fda-maude-dhr-total

See every metric in the Danaher KPI table. Data updated Nov 2, 2026.